Interestingly, tumor molecular classification showed that circRNAs were prevalently downregulated in the early disease stages, particularly stage 0-I tumors with APC but no KRAS mutations and MSI-stable CMS2 tumors, the molecular subtype characterized by WNT and MYC mutation and an epithelial-like phenotype [42]. Here, KRAS is linked to neoplasm.